It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Nonsense and frameshift mutations of the dystrophin (DMD) gene usually cause severe Duchenne muscular dystrophy (DMD). Interestingly, however, premature stop codons in exons 1 and 2 result in relatively mild Becker muscular dystrophy (BMD). Herein, we report the clinical course of a patient with a very mild phenotype of BMD caused by a frameshift mutation, NM_004006.2: c.40_41del GA/p.(Glu14ArgfsX17), in exon 2 of the DMD gene.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 National Hospital Organization Niigata National Hospital, Department of Neurology, Kashiwazaki, Japan ; Niigata University, Department of Neurology, Brain Research Institute, Niigata, Japan (GRID:grid.260975.f) (ISNI:0000 0001 0671 5144)
2 National Hospital Organization Niigata National Hospital, Department of Pediatrics, Kashiwazaki, Japan (GRID:grid.260975.f) ; National Hospital Organization Niigata National Hospital, Department of Clinical Research, Kashiwazaki, Japan (GRID:grid.260975.f)
3 National Hospital Organization Niigata National Hospital, Deprtment of Genetic Counseling, Kashiwazaki, Japan (GRID:grid.260975.f)
4 National Hospital Organization Niigata National Hospital, Department of Neurology, Kashiwazaki, Japan (GRID:grid.260975.f)
5 National Hospital Organization Niigata National Hospital, Department of Internal Medicine, Kashiwazaki, Japan (GRID:grid.260975.f)




